163 related articles for article (PubMed ID: 34128234)
1. Evaluating the effect of secretome of human amniotic mesenchymal stromal cells on apoptosis induction and epithelial-mesenchymal transition inhibition in LNCaP prostate cancer cells based on 2D and 3D cell culture models.
Safari F; Shakery T; Sayadamin N
Cell Biochem Funct; 2021 Aug; 39(6):813-820. PubMed ID: 34128234
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression.
Alidoust Saharkhiz Lahiji M; Safari F
Biologicals; 2022 Apr; 76():24-30. PubMed ID: 35216916
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the in vitro therapeutic effects of human amniotic mesenchymal stromal cells on MiaPaca2 pancreatic cancer cells using 2D and 3D cell culture model.
Rahmani Z; Safari F
Tissue Cell; 2021 Feb; 68():101479. PubMed ID: 33383360
[TBL] [Abstract][Full Text] [Related]
4. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
Wang Y; Wu Z; Hu L
Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
[TBL] [Abstract][Full Text] [Related]
5. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line.
Deezagi A; Safari N
Mol Biol Rep; 2020 Nov; 47(11):8727-8737. PubMed ID: 33085048
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
Turini S; Bergandi L; Gazzano E; Prato M; Aldieri E
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609805
[TBL] [Abstract][Full Text] [Related]
8. A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial-Mesenchymal Transition in Prostate Cancer Cells.
Melekhova A; Leeder M; Pungsrinont T; Schmäche T; Kallenbach J; Ehsani M; Mirzakhani K; Rasa SMM; Neri F; Baniahmad A
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439818
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting glycogen synthase kinase-3 and transforming growth factor-β signaling to promote epithelial transition of human adipose mesenchymal stem cells.
Setiawan M; Tan XW; Goh TW; Hin-Fai Yam G; Mehta JS
Biochem Biophys Res Commun; 2017 Sep; 490(4):1381-1388. PubMed ID: 28698144
[TBL] [Abstract][Full Text] [Related]
10. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
11. Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells.
Burton LJ; Barnett P; Smith B; Arnold RS; Hudson T; Kundu K; Murthy N; Odero-Marah VA
BMC Complement Altern Med; 2014 Mar; 14():97. PubMed ID: 24617993
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S
Gene; 2020 Mar; 730():144264. PubMed ID: 31759982
[TBL] [Abstract][Full Text] [Related]
14. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis.
Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J
Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093
[TBL] [Abstract][Full Text] [Related]
15. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
16. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
Azizi R; Fallahian F; Aghaei M; Salemi Z
Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-105 promotes epithelial-mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl-1.
Jin X; Yu Y; Zou Q; Wang M; Cui Y; Xie J; Wang Z
J Cell Biochem; 2019 Apr; 120(4):5880-5888. PubMed ID: 30317672
[TBL] [Abstract][Full Text] [Related]
18. Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition.
Hodge DQ; Cui J; Gamble MJ; Guo W
Sci Rep; 2018 Jan; 8(1):841. PubMed ID: 29339820
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of anti-tumor activity of novel triazolo[1,5-a] pyrimidine on cancer cells by induction of cellular apoptosis and inhibition of epithelial-to-mesenchymal transition process.
Safari F; Bayat M; Nasri S; Karami S
Bioorg Med Chem Lett; 2020 May; 30(10):127111. PubMed ID: 32199733
[TBL] [Abstract][Full Text] [Related]
20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
